JohnVictorConteJr.MD

Adult Cardiac Surgery, Aortic Surgery, Minimally Invasive Cardiac Surgery, Cardiovascular Surgery

Attending Cardiac Surgeon

Overview of Dr. Conte

Dr. John Conte is a thoracic surgeon in Baltimore, MD and is affiliated with MedStar Health System. He received his medical degree from Georgetown University School of Medicine and trained in Cardiothoracic Surgery at Stanford University. He has been in practice 32 years. He specializes in adult cardiac surgery, aortic surgery, minimally invasive cardiac surgery, and cardiovascular surgery.

Office
Cardiac Surgery
201 E University Parkway
Baltimore, MD 21218
Book by Phone+1(667) 207-2773
Is this information wrong?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Thoracic Surgery, 1992 - 1995
MedStar HealthResidency, 1986 - 1992
Georgetown University School of MedicineClass of 1986

Certifications & Licensure

CA State Medical License 1993 - Present
FL State Medical License 2020 - 2026
MD State Medical License 1995 - 2026
IN State Medical License 2024 - 2025
MO State Medical License 2024 - 2025
DE State Medical License 2023 - 2025
PA State Medical License 2017 - 2024
IA State Medical License 2023 - 2024
DC State Medical License 1989 - 2000
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Join now to see all

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Fellow (FACS) American College of Surgeons
Castle Connelly Top Doctor 2018
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Join now to see all

Clinical Trials

The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation Start of enrollment: 1999 Oct 01
Completed
Phase 2, Phase 3
The Effect of Cold Storage Solutions on Ischemic Injury in Lung Transplantation Start of enrollment: 2000 Dec 01
Completed
Phase 3
Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Start of enrollment: 2007 Nov 01
Terminated
Phase 1, Phase 2
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
Active, not recruiting
Not Applicable
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

24 citations
Preoperative performance status impacts perioperative morbidity and mortality after lung transplantation.
Joshua C. Grimm, Vicente Valero, Arman Kilic, Todd C. Crawford, John V. Conte
The Annals of Thoracic Surgery. 2015-02-01
768 citations
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
Jeffrey J. Popma, David H. Adams, Michael J. Reardon, Steven J. Yakubov, Neal S. Kleiman
Journal of the American College of Cardiology. 2014-05-20
140 citations
Biomaterial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
Chin Siang Ong, Takuma Fukunishi, Huaitao Zhang, Chen-Yu Huang, Andrew Nashed
Scientific Reports. 2017-07-04

Journal Articles

Original Investigation Self-Expanding Transcatheter Aortic Valve Replacement or Surgical Valve Replacement in High-Risk Patients: 5-Year Outcomes
G Michael Deeb, Steven J Yakubov, Joon S Lee, Thomas G Gleason, William Merhi, George Petrossian, G Chad Hughes, David H Adams, Neal S Kleiman, Jeffrey J Popma, Mubash..., ScienceDirect